| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/18/2008 | US20080312343 Novel Concentrated Inverse Latex, Process for Preparing It and Industrial Use Thereof |
| 12/18/2008 | US20080312342 Process for the Production of Diacylglycerol |
| 12/18/2008 | US20080312341 Mono-, di- and polyol phosphate esters in personal care formulations |
| 12/18/2008 | US20080312340 Process for Preparing Dispersions |
| 12/18/2008 | US20080312338 Formulation |
| 12/18/2008 | US20080312219 Biologically active methylene blue derivatives |
| 12/18/2008 | US20080312204 Soluble forms of amoxicillin and treatment of animals |
| 12/18/2008 | US20080312195 Preservatives |
| 12/18/2008 | US20080312136 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 12/18/2008 | US20080312135 Mixtures of drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 12/18/2008 | US20080312134 Vesicles for active macromolecule delivery |
| 12/18/2008 | US20080312130 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same |
| 12/18/2008 | US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12 |
| 12/18/2008 | US20080311396 Pressure-Sensitive Adhesive Sheet for Application to Skin |
| 12/18/2008 | US20080311223 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | US20080311211 Easily Dispersible Lipidic Phase |
| 12/18/2008 | US20080311209 Topical compositions comprising nanoparticles of an isoflavone |
| 12/18/2008 | US20080311208 Pharmaceutical Formulations Useful in the Treatment of Insomnia |
| 12/18/2008 | US20080311199 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311182 Multistage delivery of active agents |
| 12/18/2008 | US20080311174 Food and Process for Producing Food |
| 12/18/2008 | US20080311136 Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation |
| 12/18/2008 | US20080311105 Reversibly Inactivated Acidified Plasmin |
| 12/18/2008 | US20080311080 Bifidobacterium in the treatment of inflammatory disease |
| 12/18/2008 | US20080311045 Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| 12/18/2008 | US20080308744 Serum Albumin Conjugated to Fluorescent Substances for Imaging |
| 12/18/2008 | CA2840407A1 Compositions and methods for producing bioactive fusion proteins |
| 12/18/2008 | CA2692164A1 Hyperbranched polymers based on cyclodextrins and poly(amidoamines) for the controlled release of insoluble drugs |
| 12/18/2008 | CA2690905A1 Recombinant transferrin mutants |
| 12/18/2008 | CA2690771A1 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | CA2690715A1 Peptide slow-release formulations |
| 12/18/2008 | CA2687995A1 Compositions and particles containing cellulosic fibers and stabilized- and/or activated-urease inhibitors, as well as methods of making and using the same |
| 12/18/2008 | CA2687979A1 Sustained delivery formulations of risperidone compounds |
| 12/18/2008 | CA2687717A1 Formulations and methods for treating dry eye |
| 12/18/2008 | CA2687178A1 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 12/18/2008 | CA2687172A1 Anti-norovirus agent and composition containing the same |
| 12/18/2008 | CA2686548A1 Concentrate esmolol |
| 12/17/2008 | EP2003451A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 12/17/2008 | EP2003142A1 Amorphous perindopril erbumine |
| 12/17/2008 | EP2003140A2 Galactose derivative, drug carrier and medicinal composition |
| 12/17/2008 | EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity |
| 12/17/2008 | EP2002847A1 Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device |
| 12/17/2008 | EP2002832A2 Composition containing lignan compound |
| 12/17/2008 | EP2002828A2 Solid pharmaceutical preparation |
| 12/17/2008 | EP2002826A1 Titratable dosage transdermal delivery system |
| 12/17/2008 | EP2002733A1 Natural honey-containing compositions and method of preparation |
| 12/17/2008 | EP2001528A1 Reverse phase osteoconductive composition |
| 12/17/2008 | EP2001515A2 Ige directed dna vaccination |
| 12/17/2008 | EP2001514A1 Preparation of micro or nano systems based on inorganic oxides with controlled porosity for carrying biologically active or activable substances |
| 12/17/2008 | EP2001513A1 Thermosensitive polyphosphazene-bioactive molecule conjugates, preparation method therof and use thereof |
| 12/17/2008 | EP2001500A2 Formulations for ecallantide |
| 12/17/2008 | EP2001497A2 Pharmaceutical compositions |
| 12/17/2008 | EP2001489A2 Pharmaceutical compositions for promoting wound healing |
| 12/17/2008 | EP2001450A2 Directly compressible composite for orally disintegrating tablets |
| 12/17/2008 | EP2001446A2 Formulations of sitaxsentan sodium |
| 12/17/2008 | EP1833855B1 Method for controlling the dimensions and the morphology of nanostructural polymeric materials, materials thereby obtained and uses thereof |
| 12/17/2008 | EP1703896B1 Pharmaceutical compositions comprising midazolam in a high concentration |
| 12/17/2008 | EP1641434B1 Pharmaceutical formulations for intranasal administration of protein comprising chitosan or a derivative thereof |
| 12/17/2008 | EP1539201B1 Antipyrotic and method of manufacturing the same |
| 12/17/2008 | EP1503772B1 Soluble composition containing sporopollenin and the use thereof |
| 12/17/2008 | EP1453489A4 Acetaminophen compositions |
| 12/17/2008 | EP1450739A4 Hydrating nasal gel and applicator |
| 12/17/2008 | EP1448186B1 Medicament for the treatment of viral skin and tumour diseases |
| 12/17/2008 | EP1377284B1 Controlled release arginine formulations |
| 12/17/2008 | EP1333865B1 Inorganic low density radionuclide coated particles |
| 12/17/2008 | EP1330244B1 Compositions comprising modafinil compounds |
| 12/17/2008 | EP1229917B1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 12/17/2008 | EP1141232B1 Preservation of sensitive biologicial materials at ambient temperatures by vitrification |
| 12/17/2008 | EP1007696B1 Il-13 receptor specific chimeric proteins and uses thereof |
| 12/17/2008 | EP0910342B1 Temperature sensitive gel for sustained delivery of protein drugs |
| 12/17/2008 | EP0859603B1 Sustained release matrix for high-dose insoluble drugs |
| 12/17/2008 | CN101325976A Use of polyvinyl lactam-polyalkylene block copolymers as solubilisers for poorly water-soluble compounds |
| 12/17/2008 | CN101325975A Copolymers based on polyalkylene oxide-modified n-vinyl lactam copolymers |
| 12/17/2008 | CN101325968A Anti-CTLA-4 antibody compositions |
| 12/17/2008 | CN101325945A Powder compositions for inhalation |
| 12/17/2008 | CN101325944A Compositions for nasal delivery |
| 12/17/2008 | CN101323022A Method for preparing gold magnetic core-shell nano-particle |
| 12/17/2008 | CN101322853A Gel composition and use thereof |
| 12/17/2008 | CN101322848A Composition for gastroscopy and preparation thereof |
| 12/17/2008 | CN101322847A Anti-hepatitis b virus gene medicament based on siRNA pool interference and mediated by complex carrier |
| 12/17/2008 | CN101322846A Compositions containing inclusion complexes |
| 12/17/2008 | CN101322845A Erianin inclusion compound |
| 12/17/2008 | CN101322839A Formulation for increasing calcium absorption |
| 12/17/2008 | CN101322838A Formulation for replenishing calcium |
| 12/17/2008 | CN101322837A Formulation for increasing bone density |
| 12/17/2008 | CN101322836A Formulation for improving bone metabolism |
| 12/17/2008 | CN101322835A Composite type formulation for replenishing calcium |
| 12/17/2008 | CN101322833A Sedative and brain-invigorating oral liquid with improved clarity and stability and preparation thereof |
| 12/17/2008 | CN101322829A Paste formulation for resolving stasis of deferent duct and treating male infertility |
| 12/17/2008 | CN101322817A Compound flavescent sophora root sustained-release dropping pill and preparation thereof |
| 12/17/2008 | CN101322784A Medicament with stomach-regulating and antidiarrheal efficacy and producing method thereof |
| 12/17/2008 | CN101322778A Double-layer sustained release tablets for compensating iron and preparation thereof |
| 12/17/2008 | CN101322768A Medical ointment for treating burn and scald |
| 12/17/2008 | CN101322755A Medicament composition, external-use paste and preparation thereof |
| 12/17/2008 | CN101322747A Medicament for treating mammitis |
| 12/17/2008 | CN101322727A Exterior patch for freeing collateral vessels and dispelling pain and producing method thereof |
| 12/17/2008 | CN101322722A Compound carbamylcholine chloride injection for animals and preparation method thereof |